GLUE — Monte Rosa Therapeutics, Inc. stock price, charts and financials

QT48Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
12.13
-0.47-3.73%
OverviewShort InterestFilings
GLUEQT48Monte Rosa Therapeutics, Inc.·NASDAQ
12.13-3.73%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 08, 20268-KCurrent report
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20264Statement of changes in beneficial ownership
Jul 08, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 07, 20264Statement of changes in beneficial ownership
Jul 06, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 06, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 25, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
#1 / 25 of 344
Page
▼
/ 14